Biopharma Insights-Thought Leadership from Marketers | Sponsored Content | CEVEC
Reduction of Product-related Impurities during Production of recombinant Adeno-Associated Viruses
Dr. Michelle Hussong, Head of Molecular Biology - Technology and Assay Development, CEVEC Pharmaceuticals GmbH;Dr. Tobias Bonifert, Head of Vector Technology, CEVEC Pharmaceuticals GmbH;Prof. Dr. Nico Scheer, Senior Consultant Business Development, CEVEC Pharmaceuticals GmbH, Professor in Molecular Biology at FH Aachen, University of Applied Sciences, Germany
June 9th 2022
